X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE DR. REDDYS LAB TTK HEALTHCARE/
DR. REDDYS LAB
 
P/E (TTM) x 21.7 31.5 69.0% View Chart
P/BV x 7.3 3.4 216.5% View Chart
Dividend Yield % 0.4 0.8 50.9%  

Financials

 TTK HEALTHCARE   DR. REDDYS LAB
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
DR. REDDYS LAB
Mar-18
TTK HEALTHCARE/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs6632,788 23.8%   
Low Rs3991,902 21.0%   
Sales per share (Unadj.) Rs535.6860.8 62.2%  
Earnings per share (Unadj.) Rs15.957.1 27.9%  
Cash flow per share (Unadj.) Rs20.0122.0 16.4%  
Dividends per share (Unadj.) Rs4.0020.00 20.0%  
Dividend yield (eoy) %0.80.9 88.3%  
Book value per share (Unadj.) Rs137.6757.7 18.2%  
Shares outstanding (eoy) m7.77165.91 4.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.02.7 36.4%   
Avg P/E ratio x33.341.1 81.1%  
P/CF ratio (eoy) x26.519.2 138.0%  
Price / Book Value ratio x3.93.1 124.7%  
Dividend payout %25.135.0 71.6%   
Avg Mkt Cap Rs m4,127389,034 1.1%   
No. of employees `0001.723.5 7.3%   
Total wages/salary Rs m60732,149 1.9%   
Avg. sales/employee Rs Th2,436.76,070.8 40.1%   
Avg. wages/employee Rs Th355.21,366.6 26.0%   
Avg. net profit/employee Rs Th72.5402.5 18.0%   
INCOME DATA
Net Sales Rs m4,162142,810 2.9%  
Other income Rs m611,552 3.9%   
Total revenues Rs m4,223144,362 2.9%   
Gross profit Rs m19723,512 0.8%  
Depreciation Rs m3210,772 0.3%   
Interest Rs m30788 3.8%   
Profit before tax Rs m19713,504 1.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m0344 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m734,380 1.7%   
Profit after tax Rs m1249,468 1.3%  
Gross profit margin %4.716.5 28.8%  
Effective tax rate %37.032.4 114.1%   
Net profit margin %3.06.6 44.9%  
BALANCE SHEET DATA
Current assets Rs m1,629104,984 1.6%   
Current liabilities Rs m1,05868,938 1.5%   
Net working cap to sales %13.725.2 54.3%  
Current ratio x1.51.5 101.1%  
Inventory Days Days3074 40.0%  
Debtors Days Days34104 32.4%  
Net fixed assets Rs m556104,385 0.5%   
Share capital Rs m78830 9.4%   
"Free" reserves Rs m878124,886 0.7%   
Net worth Rs m1,069125,716 0.9%   
Long term debt Rs m15925,089 0.6%   
Total assets Rs m2,399225,443 1.1%  
Interest coverage x7.618.1 41.8%   
Debt to equity ratio x0.10.2 74.4%  
Sales to assets ratio x1.70.6 273.8%   
Return on assets %6.44.5 140.9%  
Return on equity %11.67.5 153.9%  
Return on capital %18.59.7 190.1%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m3372,623 0.0%   
Fx outflow Rs m6318,916 0.3%   
Net fx Rs m-3053,707 -0.1%   
CASH FLOW
From Operations Rs m12718,030 0.7%  
From Investments Rs m-146-14,883 1.0%  
From Financial Activity Rs m22-4,440 -0.5%  
Net Cashflow Rs m3-1,236 -0.2%  

Share Holding

Indian Promoters % 65.4 25.5 256.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 5.4 68.5%  
FIIs % 5.2 35.3 14.7%  
ADR/GDR % 0.0 18.5 -  
Free float % 25.8 15.3 168.6%  
Shareholders   12,723 75,885 16.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ALKEM LABORATORIES  PLETHICO PHARMA  GLENMARK PHARMA  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Lower; Realty & Auto Stocks Top Losers(09:30 am)

Asian shares eased in holiday-thinned trading on Monday and the safe haven yen gained as China canceled upcoming tariff talks with the United States.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 24, 2018 09:53 AM

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS